ARRive Growth Partners made its Commercialization Assessment available at no cost to help healthtech founders understand where Commercialization Debt may exist and what to strengthen next.

ARRive Growth Partners helps healthtech startups build the commercialization maturity required to turn product traction into predictable growth. Product maturity and commercialization maturity rarely happen at the same speed. A company can have a strong product, early customers, and a validated market opportunity while still lacking the commercial infrastructure required to scale. Over time, that gap creates Commercialization Debt™: the accumulated constraints that make growth increasingly difficult, expensive, and dependent on the founder. The ARRive Commercialization Framework™ identifies where those constraints exist, determines what is limiting growth, and builds the commercialization capabilities required to address them. Through our Commercialization Assessment™, we establish the company's current commercialization state and identify the constraints standing between where the business is today and where it needs to go. We then work alongside leadership through the ARRive Commercialization System™ to build the capabilities, operating discipline, and commercial infrastructure required to reduce Commercialization Debt™, strengthen execution, and create a more predictable path to ARR. ARRive is not a fractional sales team, marketing agency, or traditional advisory firm. We don't advise. We execute.

Founded 2025